Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: homes  hurricane  disaster  clayton  mexico  style  help  story  multivu  8335052  cancer  kids  childhood  micah  awareness  st  baldrick  foundation  research  health  medical  multivu  8284352  pancreatic  cancer  detection  awareness  treatment  disease  health  multivu  8213751  clayton  building  house  home  tennessee  children  hospital  cancer  multivu  80116510  pancreatic  cancer  health  awareness  disease  detection  early  prevention  diagnose  multivu  8201651  childhood  cancer  tumor  health  research  hospital  st  jude  medical  overview  multivu  8121952  entertainment  espanol  discovery  show  tv  desafio  x  2  mexico  survival  skills  multivu  8010451  cancer  leukemia  lymphoma  lls  health  healthcare  cure  treatment  aml  multivu  7554854  soy  health  food  women  breast  cancer  myth  cancer  research  safety  multivu  7877951  rare  life  award  military  medal  of  honor  veterans  eagle  rare  whisky  bourbon  multivu  7761951  research  astro  science  cancer  early  stage  breast  cancer  health  technology  advancement  doctors  multivu  7661231  research  astro  science  cancer  early  stage  breast  cancer  health  technology  advancement  doctors  multivu  7661231 
Search // survival
Results 1-12 of 70 for ' survival ' (0 seconds)
Clayton, one of America’s leading builders of prefabricated homes, has released a new video featuring the story of a family whose Clayton Built® home survived the devastating Category Four Hurricane Michael. When the hurricane made landfall Oct.10, Darla and Terry’s Clayton Built® home was along its path. The two moved to Mexico Beach, Fla. from Alabama after retirement to be closer to the beach. They originally planned to build a site built home on their newly purchased property, but after learning more about Clayton and touring the company’s Clayton SE Homes home building facility in Addison, Ala., the couple opted to purchase a Clayton Built® home from Clayton Homes of Panama City instead. To view the multimedia release go to: https://www.multivu.com/players/English/8335052-clayton-built-home-mexico-beach-hurricane-michael/
Categories // Miscellaneous 
Added: 1280 days ago by MultiVuVideos
Runtime: 2m50s | Views: 420 | Comments: 1
Not yet rated
 

 

 

When a child is diagnosed with cancer, their family is presented with treatment options – often a combination of surgery, radiation and chemotherapy. Radiation and chemotherapy have been used to treat kids’ cancers for more than 50 years and often come with long-term late effects including secondary cancers, heart damage and cognitive issues. Often a child’s best chance at survival is a clinical trial which offers them the newest treatment options available. In recognition of Childhood Cancer Awareness Month, the St. Baldrick’s Foundation will highlight the critical need to fund lifesaving research and share stories of kids affected by cancer – like Micah, who is alive today because there was a clinical trial available. To view the multimedia release go to: https://www.multivu.com/players/English/8284352-st-baldricks-foundation-conquer-childhood-cancers/
Categories // Miscellaneous 
Added: 1396 days ago by MultiVuVideos
Runtime: 2m26s | Views: 401 | Comments: 1
Not yet rated
 

 

 

Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers. “The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.” To view the multimedia release go to: https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
Categories // Miscellaneous 
Added: 1623 days ago by MultiVuVideos
Runtime: 2m0s | Views: 313 | Comments: 2
Not yet rated
 

 

 

Clayton, one of the largest home builders in America, helped fulfill the dreams of an East Tennessee Children’s Hospital cancer patient by giving him the opportunity to design a Clayton home using CAD software commonly used at home building facilities. Jake Clark, 16, became an honorary member of the Clayton team on Nov. 22 during a special ‘Team Jake’ celebration event at a home building facility in Bean Station, Tenn. His interests in construction projects with his dad, a home contractor, and his talents in drawing and 3D design made Jake the perfect fit to visit Clayton. While visiting the home building facility, the cancer survivor sat with a home designer and created a home model floor plan of his own, which was named “The Jake” in his honor. To view the multimedia release go to: https://www.multivu.com/players/English/80116510-clayton-honors-young-cancer-survivor/
Categories // Miscellaneous 
Added: 1655 days ago by MultiVuVideos
Runtime: 7m23s | Views: 369 | Comments: 2
Not yet rated
 

 

 

In honor of World Pancreatic Cancer Day on Nov. 16, people around the world will come together to Demand Better in the fight against the world’s toughest cancer, starting with earlier diagnosis. The annual one-day campaign is an initiative of the World Pancreatic Cancer Coalition, which is comprised of more than 60 organizations from 27 countries on six continents. Every day, more than 1,000 people worldwide will be diagnosed with pancreatic cancer. Of that, an estimated 985 will die from the disease. Additionally, pancreatic cancer has the lowest survival rate among all major cancers, and in nearly every country, it is the only major cancer with a single-digit five-year survival rate (2-9 percent). These stunning figures are not merely statistics, they represent family members, friends and colleagues on every corner of the globe. “This year, we are turning World Pancreatic Cancer Day from a day of awareness to a day of action,” said Julie Fleshman, JD, MBA, World Pancreatic Cancer Coalition chair. “As we expand our global movement to end pancreatic cancer, we are demanding better for pancreatic cancer patients now and in the future.” To view the multimedia release go to: https://www.multivu.com/players/English/8201651-world-pancreatic-cancer-day-demand-better/
Categories // Miscellaneous 
Added: 1709 days ago by MultiVuVideos
Runtime: 1m3s | Views: 313 | Comments: 2
Not yet rated
 

 

 

In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community. St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature. “Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.” To view the multimedia release go to: https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Categories // Miscellaneous 
Added: 1764 days ago by MultiVuVideos
Runtime: 1m34s | Views: 310 | Comments: 0
Not yet rated
 

 

 

Discovery en Español welcomes the new year with adrenaline-filled premieres on its popular programming block ‘Jueves de Aventura,’ highlighting the original production DESAFÍO X 2: MÉXICO, where two survival experts from Colombia and México, will test their skills in inhospitable territories of Chiapas, Veracruz and Puebla. DESAFÍO X 2: MÉXICO premieres January 12 and will air on Thursdays at 11PM E/P. Each of the six episodes will feature Colombian adventurer Daniel Tirado and Mexican army veteran Alberto Pegueros surviving in extremely remote wild Aztec lands and putting their skills and knowledge into practice in order to make their way back to civilization safe and sound. Together, they have to avoid danger, predators, and find food, water and shelter. However, conflicts are not only limited to wilderness, and each man’s survival skills might not always match those of his partner, so combining techniques and living together could become the greatest of challenges for both men. To view the multimedia release go to: http://www.multivu.com/players/English/8010451-discovery-en-espanol-2017-premieres/
Categories // Miscellaneous 
Added: 1996 days ago by MultiVuVideos
Runtime: 0m30s | Views: 329 | Comments: 2
Not yet rated
 

 

 

Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years. Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government. AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60. To view the multimedia release go to: http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
Categories // Miscellaneous 
Added: 2081 days ago by MultiVuVideos
Runtime: 0m59s | Views: 377 | Comments: 0
Not yet rated
 

 

 

Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom. 1) Eating soy does not increase breast cancer risk. Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9 “Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods. To view the multimedia release go to: http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
Categories // Miscellaneous 
Added: 2150 days ago by MultiVuVideos
Runtime: 2m29s | Views: 450 | Comments: 0
Not yet rated
 

 

 

Eagle Rare Kentucky Straight Bourbon Whiskey has named Hershel “Woody” Williams of Ona, West Virginia, as the Grand Prize winner of the 2016 Rare Life Award. Eagle Rare will donate $50,000 to Williams’ charity, the Hershel “Woody” Williams Medal of Honor Foundation, and host an awards ceremony in Lexington, Kentucky on February 27, 2016. The Rare Life Award is an annual recognition program created to honor individuals who exhibit courage, leadership, survival, devotion, character and heroism. Candidates are nominated by friends, family and colleagues. Their stories and photos are posted online at www.eaglerarelife.com. To view the multimedia release go to: http://www.multivu.com/players/English/7761951-2016-rare-life-award/
Categories // Miscellaneous 
Added: 2320 days ago by MultiVuVideos
Runtime: 6m23s | Views: 545 | Comments: 0
Not yet rated
 

 

 

Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated. Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal. “We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.” To view the multimedia release go to: http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Categories // Miscellaneous 
Added: 2438 days ago by MultiVuVideos
Runtime: 1m25s | Views: 543 | Comments: 0
Not yet rated
 

 

 

Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated. Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal. “We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.” To view the multimedia release go to: http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Categories // Miscellaneous 
Added: 2438 days ago by MultiVuVideos
Runtime: 3m4s | Views: 533 | Comments: 0
Not yet rated
 

 

 

Page 1 of 6  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2022 ClipMoon.com. All rights reserved.